Lactoferrin in Sjögren's Syndrome

Ophthalmology

Volumn 114, Issue 12, 2007, Pages

  Dogru, Murat ^a   Matsumoto, Yukihiro ^a   Yamamoto, Yusuke ^a   Goto, Eiki ^a   Saiki, Megumi ^a   Shimazaki, Jun ^a   Takebayashi, Toru ^a   Tsubota, Kazuo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; CYCLOSPORIN; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LACTOFERRIN; STEROID; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; BIOMICROSCOPY; CELL DENSITY; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC VALUE; DRY EYE; EYE DISEASE; EYE EXAMINATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERFEROMETRY; LACRIMATION; LETTER; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SJOEGREN SYNDROME; SQUAMOUS CELL METAPLASIA;

EID: 36548999785     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.06.027     Document Type: Letter

References (6)

1. Conneely O.M. Antiinflammatory activities of lactoferrin. J Am Coll Nutr 20 5 suppl (2001) 389S-395S
2. Brock J.H. Lactoferrin: an overview of research and prospects. Milk Sci 53 (2004) 219-225
3. Danjo Y., Lee M., Horimoto K., and Hamano T. Ocular surface damage and tear lactoferrin in dry eye syndrome. Acta Ophthalmol (Copenh) 72 (1994) 433-437
4. Pflugfelder S.C., Jones D., Ji Z., et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res 19 (1999) 201-211
5. Fujihara T., Nagano T., Nakamura M., and Shirasawa E. Lactoferrin suppresses loss of corneal epithelial integrity in a rabbit short-term dry eye model. J Ocul Pharmacol Ther 14 (1998) 99-107
6. Chow S.C., and Liu J.P. Sample size determination. Concept and Methodologies. In: Balding D.J., and Noel A.C. (Eds). Design and Analysis of Clinical Trials (2004), Wiley Interscience, Hoboken, NJ 438-510